by Kenjiro Lolling | Apr 13, 2023 | News
Dutch start-up OncoLize has closed a US$ 1.7 million seed investment round to extend their preclinical success with a localized drug delivery system to treat Pancreatic- and Lung cancer. The round was led by corner-stone investors Libertatis Ergo Holding...
by Kenjiro Lolling | Apr 5, 2023 | News
Are you ready to join the RegMed XB 1st Annual Conference? This is the leading Regenerative Medicine event in the Netherlands on 28th and 29th June 2023 in CORPUS Leiden. What to expect? You will receive information and insights on all the different parts of RegMed...
by Kenjiro Lolling | Mar 30, 2023 | News
Graag vragen we uw medewerking aan de Life Science Stage Oriëntatiedagen op 24, 25 en 26 april 2023. Hogeschool Leiden – Faculteit Science & Technology en het mboRijnland-MLO organiseren deze week om studenten inzicht te geven in de verschillende...
by Kenjiro Lolling | Mar 17, 2023 | News
Ida has shaped the further development of the Leiden Bio Science Park since 2019. Under her leadership, the Leiden Bio Science Park (LBSP) has been further transformed into an innovation district in the field of drug development and health in recent years. The LBSP is...
by Kenjiro Lolling | Feb 10, 2023 | Uncategorized
The favorable Dutch business environment in the Greater Rotterdam-The Hague area, and specifically in Leiden, made a great impression on JCR. The central location in Europe and proximity to EMA, the high concentration of biotech and pharma in the country with major...